ClinicalTrials.Veeva

Menu

Local Treatment by Thermic Destruction of Primitive Breast Cancer (LASERBREAST1)

G

Gustave Roussy

Status and phase

Completed
Phase 2

Conditions

Breast Cancer

Treatments

Procedure: Thermic destruction of tissue by Laser using the Novilase device

Study type

Interventional

Funder types

Other

Identifiers

NCT01706016
2011/1773 (Other Identifier)
2012-A00448-35

Details and patient eligibility

About

Demonstrate the effectiveness of laser in the treatment of cancerous lesions by determinating with histological analysis of the specimen the percentage of tumor cells remaining in the area treated by the laser

Enrollment

16 estimated patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Noninflammatory unilateral and unifocal breast cancer
  • Size </= 20mm (ultrasound measure)
  • Histological confirmation of cancer by biopsy grade status hormone and HER2.
  • Good delineation of the lesion on ultrasound.
  • Minimum distance of 5 mm between the tumor and the skin between the tumor and muscle.
  • Age between 18 and 80
  • ECOG performance status 0 or 1

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16 participants in 1 patient group

Patients with breast cancer smaller than 20mm
Experimental group
Treatment:
Procedure: Thermic destruction of tissue by Laser using the Novilase device

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems